News
Early Bird Registration Ends 4/30 – Ovarian Cancer National Conference
Last chance! Our lowest rates end at 10PM Pacific on 4/30! (April 29, 2019) Don’t miss your chance to register at our discount rate of only $185…
Highlights from 2019 SGO Annual Meeting on Women’s Cancer
(April 3, 2019) In March, ovarian cancer researchers, clinicians and advocates gathered to attend the much-anticipated Society of Gynecologic Oncology’s (SGO) 50th Annual Meeting on Women’s Cancer, to discuss the latest cutting edge…
Action Alert: Tell Senate – More Funding for Ovarian Cancer Research!
(April 3, 2019) We have one week to let the Senate know that we need more funding for ovarian cancer research! Thanks to your efforts, a record 158 U.S…
Join Us for Stand Up for Madeline & OCRA on May 20th
Join us Monday, May 20th at Carolines on Broadway in NYC for an evening of laughter, plus cocktails, hors d’oeuvre and a live auction, all to end ovarian cancer…
Update on $15 Million Increase Request for OCRP Funding
(April 1, 2019) 156 House Members have joined Reps. DeLauro and Duffy in a call for increased ovarian cancer research funding. Reps…
Sign up for OCRA’s National Conference at Early Bird Registration Fee
Empower yourself with the latest research updates at OCRA’s National Conference. Register today. It can be overwhelming trying to keep up with what’s new in the ovarian cancer field, and how new discoveries may affect you…
Shop Designer Brands to End Ovarian Cancer
OCRA is now on Shopify and Poshmark Wardrobe need a refresh? Now you can shop high-end, limited quantity designer goods online at deep discounts, all while supporting the fight against ovarian cancer…
National Comprehensive Cancer Network Updates Guidelines
(March 26, 2019) The NCCN, or the National Comprehensive Cancer Network, recently updated its clinical guidelines for the treatment of ovarian cancers…
OCRA Funded Study Aims to Increase Efficacy of PARP Inhibitors
(March 20, 2019) The Ovarian Cancer Dream Team, funded in part by OCRA, recently completed a Phase 1b Trial, which combined a PARP inhibitor with an HRR (homologous recombination repair) pathway inhibitor, such as PI3K, in order to increase the…
OCRA Spring Advocacy Day 2019 Actions
(March 20, 2019) Earlier this month, OCRA united advocates from across the country for Spring Advocacy Day on Capitol Hill…
Action Alert: Tell Congress to Increase OCRP Funding
(March 19, 2019) Congress is considering a $15 million increase for OCRP funding. Urge YOUR Representative to sign the letter to help push this funding through…
Lymphadenectomy in Ovarian Cancer Patients Can Be Unnecessary
(March 18, 2019) Before the most recent study on the usage of lymphadenectomy, published earlier this month in the New England Journal of Medicine, it was thought that surgically removing clinically negative lymph nodes had a positive effect on the…